Global Healthcare ETF - Currency Hedged | BetaShares
  • Request info pack
  • Download factsheet
  • Request a call
  • Request Lonsec research
  • View all funds
  • Download Factsheet

Thank you for your request, an email will be sent to you shortly. If you don’t receive it within 30 minutes please contact info@betashares.com.au

OVERVIEW

Fund Objective

DRUG aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.

Benefits of DRUG

Healthcare – a global growth opportunity

Ageing populations, rising living standards and ongoing medical advancements are expected to support increasing ongoing demand for healthcare products and services.

Simple access to global healthcare giants

Access a diversified portfolio of the world’s leading healthcare companies, such as Johnson & Johnson, Pfizer and Roche, in one trade.

Cost-effective

Passive, index-tracking approach means no ‘active manager’ fees, making DRUG a cost-effective investment for those seeking exposure to the global healthcare sector.

How to invest

  • You can buy or sell units just like you’d buy or sell any share on the ASX.
  • Fund requires no minimum investment.

KEY FACTS

Pricing Information 9 April 2020

Current Price
Last Trade* -
% Change (prev day) -
Bid (delayed) -
Offer (delayed) -
*Data is delayed by at least 20 minutes.
Download NAV history
NAV
NAV/Unit * $6.16
* As at 8 April 2020

Profile

Net Assets* ($A) $37,007,189
Units Outstanding* (#) 6,011,695
Mgmt Costs** (% p.a.) 0.57%
Distribution Frequency Semi-annual
Distribution Reinvestment Plan (DRP) Full or partial participation available
Issuer BetaShares Capital Ltd
Fund Administrator RBC Investor Services
Custodian RBC Investor Services
Registry Link Market Services
Auditor KPMG
* As at 8 April 2020
**Certain additional costs apply. Please refer to PDS.

Trading Information

ASX Code DRUG
Bloomberg Code DRUG AU
IRESS Code DRUG.AXW
Trading Hours 10.00-16.00 (AEST)
iNAV IRESS Code N/A
Market Makers Deutsche Securities
SMSF Eligible Yes

Index Information

Index Nasdaq Global ex-Australia Healthcare Hedged AUD Index
Index Provider Nasdaq
Index Ticker N/A
Bloomberg Index Ticker NQXAUHHN Index
Index Methodology

Portfolio Holdings

Name Weight (%)
JOHNSON & JOHNSON 8.6
UNITEDHEALTH GROUP INC 5.8
ROCHE HOLDING AG 5.5
NOVARTIS AG 5.2
MERCK & CO INC 4.8
PFIZER INC 3.7
ABBOTT LABORATORIES 3.5
MEDTRONIC PLC 3.1
ELI LILLY & CO 3.0
THERMO FISHER SCIENTIFIC INC 3.0
Ticker Name Weight (%) Asset Class Sector Country Currency Shares/Unit (#) Market Value (AUD) Notional Value (AUD)
JNJ UN JOHNSON & JOHNSON 8.6 Equities Healthcare United States USD 13,624 $3,133,367 $3,133,367
UNH UN UNITEDHEALTH GROUP INC 5.8 Equities Healthcare United States USD 4,896 $2,105,146 $2,105,146
ROG SW ROCHE HOLDING AG 5.5 Equities Healthcare Switzerland CHF 3,863 $1,993,055 $1,993,055
NOVN SW NOVARTIS AG 5.2 Equities Healthcare Switzerland CHF 13,896 $1,891,884 $1,891,884
MRK UN MERCK & CO INC 4.8 Equities Healthcare United States USD 13,299 $1,742,598 $1,742,598
PFE UN PFIZER INC 3.7 Equities Healthcare United States USD 24,314 $1,350,561 $1,350,561
ABT UN ABBOTT LABORATORIES 3.5 Equities Healthcare United States USD 9,245 $1,260,817 $1,260,817
MDT UN MEDTRONIC PLC 3.1 Equities Healthcare United States USD 7,088 $1,129,710 $1,129,710
LLY UN ELI LILLY & CO 3.0 Equities Healthcare United States USD 4,698 $1,102,812 $1,102,812
TMO UN THERMO FISHER SCIENTIFIC INC 3.0 Equities Healthcare United States USD 2,230 $1,099,606 $1,099,606
AMGN UW AMGEN INC 2.9 Equities Healthcare United States USD 2,941 $1,034,898 $1,034,898
ABBV UN ABBVIE INC 2.7 Equities Healthcare United States USD 7,730 $974,906 $974,906
AZN LN ASTRAZENECA PLC 2.6 Equities Healthcare Britain GBP 6,712 $930,502 $930,502
NOVOB DC NOVO NORDISK A/S 2.5 Equities Healthcare Denmark DKK 9,530 $904,699 $904,699
BMY UN BRISTOL-MYERS SQUIBB CO 2.3 Equities Healthcare United States USD 9,060 $847,239 $847,239
SAN FP SANOFI 2.3 Equities Healthcare France EUR 5,923 $846,733 $846,733
GSK LN GLAXOSMITHKLINE PLC 2.1 Equities Healthcare Britain GBP 25,802 $769,380 $769,380
GILD UW GILEAD SCIENCES INC 2.1 Equities Healthcare United States USD 6,262 $753,873 $753,873
CI UN CIGNA CORP 1.5 Equities Healthcare United States USD 1,828 $546,492 $546,492
ZTS UN ZOETIS INC 1.5 Equities Healthcare United States USD 2,649 $541,155 $541,155
BDX UN BECTON DICKINSON AND CO 1.5 Equities Healthcare United States USD 1,323 $530,984 $530,984
ANTM UN ANTHEM INC 1.4 Equities Healthcare United States USD 1,311 $519,896 $519,896
BAYN GY BAYER AG 1.4 Equities Healthcare Germany EUR 5,135 $508,934 $508,934
SYK UN STRYKER CORP 1.4 Equities Healthcare United States USD 1,790 $506,999 $506,999
ISRG UW INTUITIVE SURGICAL INC 1.2 Equities Healthcare United States USD 553 $453,213 $453,213
BIIB UW BIOGEN INC 1.2 Equities Healthcare United States USD 873 $444,208 $444,208
VRTX UW VERTEX PHARMACEUTICALS INC 1.2 Equities Healthcare United States USD 1,072 $429,660 $429,660
4502 JT TAKEDA PHARMACEUTICAL CO LTD 1.2 Equities Healthcare Japan JPY 8,200 $421,582 $421,582
4568 JT DAIICHI SANKYO CO LTD 1.0 Equities Healthcare Japan JPY 3,300 $366,375 $366,375
EW UN EDWARDS LIFESCIENCES CORP 1.0 Equities Healthcare United States USD 1,102 $366,301 $366,301
BAX UN BAXTER INTERNATIONAL INC 1.0 Equities Healthcare United States USD 2,698 $365,913 $365,913
BSX UN BOSTON SCIENTIFIC CORP 1.0 Equities Healthcare United States USD 6,434 $362,861 $362,861
REGN UW REGENERON PHARMACEUTICALS INC 1.0 Equities Healthcare United States USD 426 $350,381 $350,381
HUM UN HUMANA INC 1.0 Equities Healthcare United States USD 641 $347,060 $347,060
EL FP ESSILORLUXOTTICA SA 0.8 Equities Consumer Discretionary France EUR 1,650 $304,916 $304,916
PHIA NA KONINKLIJKE PHILIPS NV 0.8 Equities Healthcare Netherlands EUR 4,782 $303,544 $303,544
CNC UN CENTENE CORP 0.8 Equities Healthcare United States USD 2,839 $296,935 $296,935
7741 JP HOYA CORP 0.8 Equities Healthcare Japan JPY 2,000 $293,819 $293,819
ILMN UW ILLUMINA INC 0.8 Equities Healthcare United States USD 637 $287,351 $287,351
LONN SW LONZA GROUP AG 0.8 Equities Healthcare Switzerland CHF 414 $274,610 $274,610
4503 JT ASTELLAS PHARMA INC 0.7 Equities Healthcare Japan JPY 10,000 $250,575 $250,575
HCA UN HCA HEALTHCARE INC 0.7 Equities Healthcare United States USD 1,414 $245,299 $245,299
4519 JT CHUGAI PHARMACEUTICAL CO LTD 0.7 Equities Healthcare Japan JPY 1,200 $241,684 $241,684
COLOB DC COLOPLAST A/S 0.6 Equities Healthcare Denmark DKK 980 $227,381 $227,381
IQV UN IQVIA HOLDINGS INC 0.6 Equities Healthcare United States USD 1,014 $208,156 $208,156
4543 JT TERUMO CORP 0.6 Equities Healthcare Japan JPY 3,700 $203,864 $203,864
ZBH UN ZIMMER BIOMET HOLDINGS INC 0.5 Equities Healthcare United States USD 1,086 $194,012 $194,012
ALC SW ALCON INC 0.5 Equities Healthcare Switzerland CHF 2,298 $188,856 $188,856
4578 JT OTSUKA HOLDINGS CO LTD 0.5 Equities Healthcare Japan JPY 2,800 $177,147 $177,147
RMD US RESMED INC 0.5 Equities Healthcare United States USD 711 $177,105 $177,105
IDXX UW IDEXX LABORATORIES INC 0.5 Equities Healthcare United States USD 424 $173,391 $173,391
INCY UW INCYTE CORP 0.4 Equities Healthcare United States USD 1,138 $160,314 $160,314
ALXN UW ALEXION PHARMACEUTICALS INC 0.4 Equities Healthcare United States USD 997 $157,753 $157,753
FRE GY FRESENIUS SE & CO KGAA 0.4 Equities Healthcare Germany EUR 2,170 $143,645 $143,645
SN/ LN SMITH & NEPHEW PLC 0.4 Equities Healthcare Britain GBP 4,622 $138,061 $138,061
068270 KS CELLTRION INC 0.4 Equities Healthcare South Korea KRW 472 $129,017 $129,017
FME GY FRESENIUS MEDICAL CARE AG & CO 0.4 Equities Healthcare Germany EUR 1,168 $128,325 $128,325
4507 JT SHIONOGI & CO LTD 0.3 Equities Healthcare Japan JPY 1,500 $122,235 $122,235
ALGN UW ALIGN TECHNOLOGY INC 0.3 Equities Healthcare United States USD 381 $112,795 $112,795
COO US COOPER COS INC/THE 0.3 Equities Healthcare United States USD 232 $110,778 $110,778
DKK DKK - DANISH KRONE 0.1 Cash DKK 148,991 $34,799 $34,799
USD USD - UNITED STATES DOLLAR 0.1 Cash USD 13,341 $21,417 $21,417
JPY JPY - JAPANESE YEN 0.1 Cash JPY 1,331,222 $19,628 $19,628
GBP GBP - BRITISH POUND 0.0 Cash GBP 7,735 $15,382 $15,382
AUD AUD - AUSTRALIA DOLLAR 0.0 Cash AUD 4,569 $4,569 $4,569
KRW KRW - KOREAN WON 0.0 Cash KRW 1,465,746 $1,935 $1,935
CHF CHF - SWISS FRANC 0.0 Cash CHF 1,020 $1,685 $1,685
EUR EUR - EURO 0.0 Cash EUR 779 $1,359 $1,359
CAD CAD - CANADA DOLLAR 0.0 Cash CAD 134 $153 $153
AUD AUD - AUSTRALIA DOLLAR FX Forwards AUD 35,362,183 $35,362,183
CHF CHF - SWISS FRANC FX Forwards CHF -2,586,218 -$4,270,505
DKK DKK - DANISH KRONE FX Forwards DKK -4,813,941 -$1,124,359
EUR EUR - EURO FX Forwards EUR -1,242,536 -$2,166,206
GBP GBP - BRITISH POUND FX Forwards GBP -935,845 -$1,861,119
JPY JPY - JAPANESE YEN FX Forwards JPY -143,671,943 -$2,118,305
USD USD - UNITED STATES DOLLAR FX Forwards USD -14,414,449 -$23,140,872
Download CSV
* As at 8 April 2020

Sector Allocation

Healthcare
100.0%
* As of 29 February 2020

Country Allocation

United States
66.3%
Switzerland
12.2%
Japan
5.7%
Britain
5.4%
France
3.5%
Denmark
3.1%
Germany
2.5%
Netherlands
0.9%
South Korea
0.3%
* As of 29 February 2020

PERFORMANCE

Fund Returns After Fees (%)

  Fund Index
1 month -2.76% -2.89%
3 months -11.43% -11.49%
6 months -0.74% -0.65%
1 year -0.61% -1.06%
3 year p.a 6.74% 6.90%
5 year p.a - 4.91%
Since inception (p.a) 5.65% 5.84%
Inception date 4-Aug-16 -
* As at 31 March 2020

Chart

Chart Type
Past performance is not an indicator of future performance. Returns are calculated in Australian dollars using net asset value per unit at the start and end of the specified period and do not reflect brokerage or the bid ask spread that investors incur when buying and selling units on the ASX. Returns are after fund management costs, assume reinvestment of any distributions and do not take into account tax paid as an investor in the Fund. Returns for periods longer than one year are annualised. Current performance may be higher or lower than the performance shown.

DISTRIBUTIONS

Yield Information

Distribution Frequency Semi-Annual
12 Mth Distribution Yield* (%) 0.4%
12 Mth Gross Distribution Yield* (%) -
Franking Level -
*As at 29 February 2020. Yield figures are calculated by summing the prior 12 month net and gross fund per unit distributions divided by the fund closing NAV per unit. Past performance is not an indicator of future performance.

Recent Distributions

Ex Date Record Date Payment Date Distribution Unit ($) Annual Distribution Return (%) (1)
2-Jan-20 3-Jan-20 17-Jan-20 $0.02494 0.46%
2-Jan-19 3-Jan-19 17-Jan-19 $0.01869 3.71%
2-Jul-18 3-Jul-18 17-Jul-18 $0.18445 3.77%
2-Jan-18 3-Jan-18 17-Jan-18 $0.01646 0.35%
View more
1 This is the annual distribution return to the end of the relevant distribution date. The distribution return reflects the contribution to total investment return made by the Fund's distributions. It is calculated as the difference between total Fund return and NAV return. NAV return is the change in the Fund's NAV price. Total return is the NAV return plus reinvestment of all distributions back to the Fund. Past performance not indicative of future performance.

ANNOUNCEMENTS

ASX Announcements: DRUG

Download
Showing - of

RESOURCES

Factsheet - DRUG
Download
Fund Flyer - DRUG
Download
Portfolio Holdings
Download
The Investment Case for DRUG
Download
Product Disclosure Statement - Global Sector Series
Download
Annual Report - June 2019
Download
NRWT and Fund Payment Notice information - December 2019 distributions
Download
Notice of Modifications to Fund Constitution – AMIT Tax Regime
Download
Index Methodology
Download
Interim Financial Report 2018
Download
2020 BetaShares Distribution Calendar
Download
View more

LEARN MORE ABOUT DRUG

Request an info pack